KALY $15 Million In CBD Extraction Contracts And PURA Partnership Included In Upcoming Analyst Report
August 26 2019 - 2:20PM
InvestorsHub NewsWire
KALY $15 Million In CBD Extraction
Contracts And PURA Partnership Included In Upcoming Analyst
Report
Dallas, TX --
August 26, 2019 -- InvestorsHub NewsWire -- Kali-Extracts, Inc.
(Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC:
KALY) (“KALY”) today clarified that the analyst report
scheduled for release later this week to be published on Wednesday,
August 28, 2019 would include coverage on the impact of the
company’s recently announced CBD extraction contracts with hemp
farming operations worth $15 million. The analyst report will
also address KALY’s ongoing business partnership with Puration,
Inc. (USOTC:
PURA). The analyst report update initiative was triggered by
KALY’s recent CEO update on the company’s cannabis extract
biopharmaceutical business pursuing $170 billion in pharmaceutical
treatments where the CEO announced a new patent and trademark applications on
KALY’s CBD Formulation for the treatment of Chronic Obstructive
Pulmonary Disease (COPD). KALY entered the cannabis sector
last year After making a strategic acquisition in Q4 2018 of a
business with a U.S. Patented Cannabis Extraction Process.
The company has since posted 2019 YTD financials reporting 250% revenue
growth. In light of the recent updates, ongoing
analyst coverage will be updated with a new report scheduled for
publication on Wednesday August 28, 2019.
To learn more
about the company visit https://www.kali-extracts.com/
This press
release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and as such, may involve risks and uncertainties.
These forward looking statements relate to, amongst other things,
current expectation of the business environment in which the
company operates, potential future performance, projections of
future performance and the perceived opportunities in the market.
The company's actual performance, results and achievements may
differ materially from the expressed or implied in such
forward-looking statements as a result of a wide range of
factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214)
210-0459
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2023 to Apr 2024